arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

RadNet, Inc.

RDNT
$72.26 ▲ +4.05 (+5.94%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
66 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Neutral
auto_awesome

Analytical Summary

RadNet, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $5.6B
Dividend Yield
Revenue Growth 22.1%
Op. Margin -4.2%
ROIC -0.8%
FCF / Share $1.02
Trailing P/E
Price / Book 5.3x
FCF Yield 1.4%
Debt / Equity 1.01
info Valuation on last close. End-of-day price, Aug 7, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$575.63M
↑ +22.1%
Net Income Profit after all expenses
$-33.47M
↑ +11.8%
Operating Margin Operating profit as % of sales
-4.2%
↓ -181.7% 37th
FCF / Share Free cash flow per share
$1.02
↑ +83.8%
Long-Term Debt Long-term obligations
$1.09B
— -0.3%

Health Breakdown

Profitability
46
Returns
42
Financial Health
41
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters